Abstract: A system and method for facilitating communication between a control server and robotic devices are provided. An integration engine of the system identifies protocol schemes and message schemes that are supported by the control server and robotic devices. When the protocol schemes and message schemes of the control server and the robotic devices are same, the integration engine facilitates transmission and reception of instructions between the control server and the robotic devices through identified communication interfaces. When the protocol schemes and message schemes of the control server and the robotic devices are different, the integration engine translates the protocol schemes and message schemes that are received from one of the control server and the robotic devices to facilitate communication between the control server and the robotic devices through identified communication interfaces.

Abstract: A system and method for facilitating communication between a control server and robotic devices are provided. An integration engine of the system identifies protocol schemes and message schemes that are supported by the control server and robotic devices. When the protocol schemes and message schemes of the control server and the robotic devices are same, the integration engine facilitates transmission and reception of instructions between the control server and the robotic devices through identified communication interfaces. When the protocol schemes and message schemes of the control server and the robotic devices are different, the integration engine translates the protocol schemes and message schemes that are received from one of the control server and the robotic devices to facilitate communication between the control server and the robotic devices through identified communication interfaces.

Abstract: Provided is a locker system that includes a plurality of lockable doors, a security lock mechanism, and a plurality of compartments. Opening of each lockable door is controlled based on a corresponding security parameter. The security lock mechanism controls opening and closing of each lockable door based on the corresponding security parameter. Each compartment is accessible from a front side and a rear side of the locker system. An access to each compartment from the front side is controlled by a corresponding lockable door. Each compartment is open from the rear side. When a robotic apparatus, transporting one or more items associated with a process at a storage facility, aligns with the locker system from the rear side, the one or more items are accessible from the front side based on opening of one or more corresponding lockable doors of one or more compartments of the plurality of compartments.

Abstract: A method includes receiving a request to transport an item from a first location to a second location; selecting a bot for transporting the item from the first location to the second location; determining a first vertical level associated with an initial location of the selected bot and a second vertical level associated with a destination of the selected bot; determining whether the first vertical level associated is different than the second vertical level. The method further includes, in response to the determination that the first vertical level is different from the second vertical level, (a) selecting a transport device configured to transfer the selected bot from the first vertical level to the second vertical level in a vertical direction; and (b) outputting a control signal to the selected bot causing the selected bot to move to a first position associated with the selected transport device.

Abstract: Low molecular weight sulfated beta-O4 lignin (SbO4L) are potent inhibitors of coagulation with high selectivity.

Abstract: Low molecular weight sulfated beta-O4 lignin (SbO4L) are potent inhibitors of coagulation with high selectivity.

Abstract: Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. ?-O4 and ?-5 trimers and tetramers) are used as anticoagulants.

Abstract: Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. ?-O4 and ?-5 trimers and tetramers) are used as anticoagulants.

Abstract: Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. ?-O4 and ?-5 trimers and tetramers) are used as anticoagulants.

Abstract: Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. ?-O4 and ?-5 trimers and tetramers) are used as anticoagulants.

Abstract: Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. ?-O4 and ?-5 trimers and tetramers) are used as anticoagulants.

Abstract: Cinnamic acid-based oligomers and therapeutic uses thereof are provided. The oligomers are used as anti-inflammation agents, inhibitors of elastase and anti-oxidants, and in some cases (e.g. the treatment of lung disorders such as lung cancer) all three activities are simultaneously beneficial. Subsets of the oligomers (e.g. ?-O4 and ?-5 trimers and tetramers) are used as anticoagulants.